New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

Canadian Journal of Bioethics-Revue Canadienne de Bioethique, published by the Universite de Montreal, is a premier open-access journal dedicated to advancing the multidisciplinary field of bioethics since 2012. Emphasizing the complexities of ethical practices in health policy, it serves as a vital resource for researchers, professionals, and students engaged in health and philosophy. With its E-ISSN 2561-4665, the journal's content is freely accessible, fostering knowledge dissemination and academic collaboration. Although categorized in Q4 among Health Policy and Health (social science) in 2023, it holds a respectable Q2 status in Philosophy, reflecting its strong theoretical contributions. Covering a wide scope from 2018 to 2024, the journal encourages robust discourse on pressing ethical issues facing contemporary healthcare systems. For those seeking to connect with the evolving narratives in bioethics, this journal is indispensable.

South African Journal of Bioethics and Law, published by HEALTH & MEDICAL PUBLISHING GROUP, stands as a vital academic platform for discussions at the intersection of bioethics and legal studies. With an ISSN of 1999-7639, this journal has embraced an Open Access model since 2008, ensuring global accessibility for researchers, practitioners, and students alike. Based in South Africa, the journal operates from PRIVATE BAG X1, PINELANDS, CAPE TOWN 7430, and features diverse articles that span a multitude of pertinent topics across health professions, law, and public health. It proudly holds a Q3 ranking in Health Professions and Law sectors, affirming its status within the scholarly community. Notably, for the year 2023, it has achieved impressive placements in Scopus ranks, reinforcing its commitment to disseminating high-quality research and fostering dialogues that influence policy and practice in these critical domains. Researchers exploring the intricate ethical and legal dimensions of healthcare will find this journal an indispensable resource.

Monash Bioethics Review, published by SPRINGER HEIDELBERG, is a leading journal in the interdisciplinary realm of bioethics, dedicated to exploring critical issues at the intersection of health policy, philosophy, and the social sciences. With an impressive impact factor placing it in Q1 in Philosophy and notable rankings across disciplines, including Q3 in Health Policy and Medicine, it serves as an essential platform for researchers, professionals, and students alike. This journal not only aims to foster robust discourse on ethical dilemmas but also seeks to contribute to policymaking through rigorous analysis and research. Covering articles from its inception in 1994 to the present, Monash Bioethics Review remains committed to addressing contemporary ethical challenges in medicine and society, making it a vital resource for those keen on navigating the complexities of bioethical thought.

American Journal of Bioethics (ISSN: 1526-5161, E-ISSN: 1536-0075) is a premier publication in the field of bioethics, published by Routledge Journals, Taylor & Francis Ltd, renowned for its commitment to advancing scholarly discourse. Established in 2001, the journal is positioned at the forefront of ethical discussions in healthcare, evidenced by its impressive Q1 rankings in both Health Policy and Issues, Ethics, and Legal Aspects in 2023. With an emphasis on high-impact research, it holds a prestigious Scopus Rank of #1/46 in Nursing and #9/310 in Medicine, showcasing its significance in shaping bioethical considerations. Though not classified as an open access journal, its contents are integral for researchers, practitioners, and students engaged in ethical policymaking and advocacy. By addressing contemporary ethical dilemmas and legal nuances within healthcare, the American Journal of Bioethics serves as an essential resource for fostering an informed dialogue and influencing policy development across the globe.

The KENNEDY INSTITUTE OF ETHICS JOURNAL, published by the prestigious Johns Hopkins University Press, stands as a leading periodical in the realm of ethics, particularly emphasizing the intersection of health policy, social sciences, history, and philosophy of science. With an ISSN of 1054-6863 and an E-ISSN of 1086-3249, this journal has been a cornerstone of ethical discourse since its inception in 1991. Renowned for its rigorous peer-review process, the journal boasts impressive rankings, including Q1 in History and Philosophy of Science and Q2 in Health (Social Science) for 2023. Researchers, professionals, and students alike will find this journal invaluable for navigating complex ethical issues, providing a platform for innovative research and discourse. Although currently not offering Open Access, its contributions to the fields of ethics and legal aspects of health are profound, making it an essential resource for those engaged in these critical discussions.

BIOETHICS is a leading academic journal published by Wiley, dedicated to exploring the multifaceted issues at the intersection of healthcare, philosophy, and policy. With an ISSN of 0269-9702 and an E-ISSN of 1467-8519, it has established itself as a critical platform for scholarly discourse since its inception in 1987. The journal holds impressive rankings, featuring in the Q1 category in both Health (social science) and Philosophy, alongside a Q2 rating in Health Policy for 2023. This positions BIOETHICS in the top echelons of its fields, ranking 35th out of 806 in Philosophy and garnering high percentiles across relevant disciplines. By fostering a deeper understanding of ethical implications in medical and social contexts, BIOETHICS serves as an essential resource for researchers, professionals, and students committed to addressing contemporary challenges in health and policy. The journal is accessible through institutional subscriptions and offers an engaging platform for the dissemination of significant research findings and theoretical advancements, paving the way for future exploration in bioethical inquiry.

AMERICAN JOURNAL OF LAW & MEDICINE is a prestigious interdisciplinary journal published by Cambridge University Press that bridges the critical intersection of legal and medical scholarship. Since its inception in 1975, this journal has fostered scholarly dialogue surrounding complex legal issues affecting health care and medical ethics, significantly contributing to the fields of law and the social sciences. With its current impact factor highlights showcasing a Q2 ranking in Law and Q3 in Health (Social Science), along with a solid readership base, the journal appeals to researchers, legal professionals, and students alike, offering a platform for impactful research and case studies. Although it does not currently provide Open Access options, the journal continues to prioritize rigorous peer-reviewed content, ensuring that essential discussions on law and medicine remain accessible to its readership. By engaging with contemporary legal and medical issues, the AMERICAN JOURNAL OF LAW & MEDICINE plays a vital role in advancing knowledge and shaping practices within these dynamic fields.

PERSPECTIVES IN BIOLOGY AND MEDICINE, published by the esteemed Johns Hopkins University Press, has been a cornerstone of interdisciplinary dialogue since its inception in 1957. With a rich history spanning over six decades, this journal delves into the multifaceted interactions between biology and medicine, offering insights that are vital for health policy, ethics, and the philosophy of science. Recognized for its impact, it holds a Q2 ranking in the History and Philosophy of Science category and Q3 rankings in several other relevant fields as of 2023. While not an open-access publication, it provides critical analyses and discussions that are indispensable for researchers, professionals, and students alike. With its committed editorial team, PERSPECTIVES IN BIOLOGY AND MEDICINE continues to foster scholarly engagement and is poised to shape the future discourse in the biosciences.